Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Genaera patents

List of Genaera patents

List of Nicira patents

List of University of Guelph patents

List of Senseonics patents

Penetration test venture capital investors

Companies in the Electronic invoicing industry

Patents where

Current Assignee

Name

is

‌

Genaera

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7410959 Therapeutic uses for aminosterol compounds	Patent 7410959 was granted and assigned to Genaera on August, 2008 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7410959	August 12, 2008
	‌ US Patent 7208292 Nucleic acid encoding an interleukin-9 receptor variant	Patent 7208292 was granted and assigned to Genaera on April, 2007 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7208292	April 24, 2007
	‌ US Patent 7384767 Nucleic acid encoding an interleukin-9 receptor variant	Patent 7384767 was granted and assigned to Genaera on June, 2008 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7384767	June 10, 2008
	‌ US Patent 7192578 Interleukin-9 mutein peptides	Patent 7192578 was granted and assigned to Genaera on March, 2007 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7192578	March 20, 2007
	‌ US Patent 7211254 Methods for treating ICACC protein associated diseases	Patent 7211254 was granted and assigned to Genaera on May, 2007 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7211254	May 1, 2007
	‌ US Patent 7700088 Interleukin-9 mutein peptides	Patent 7700088 was granted and assigned to Genaera on April, 2010 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7700088	April 20, 2010
	‌ US Patent 7704710 Interleukin-9 receptor mutants	Patent 7704710 was granted and assigned to Genaera on April, 2010 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7704710	April 27, 2010
	‌ US Patent 7504409 Mucin synthesis inhibitors	Patent 7504409 was granted and assigned to Genaera on March, 2009 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7504409	March 17, 2009
	‌ US Patent 7345051 Mucin synthesis inhibitors	Patent 7345051 was granted and assigned to Genaera on March, 2008 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7345051	March 18, 2008
	‌ US Patent 7056698 Nucleic acids encoding interleukin-9 receptor variants	Patent 7056698 was granted and assigned to Genaera on June, 2006 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7056698	June 6, 2006
	‌ US Patent 6933383 Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols	Patent 6933383 was granted and assigned to Genaera on August, 2005 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	6933383	August 23, 2005
	‌ US Patent 7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders	Patent 7074778 was granted and assigned to Genaera on July, 2006 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	7074778	July 11, 2006
	‌ US Patent 6962909 Treatment of neovascularization disorders with squalimine	Patent 6962909 was granted and assigned to Genaera on November, 2005 by the United States Patent and Trademark Office.		‌ Genaera		United States Patent and Trademark Office	6962909	November 8, 2005

13 results

0 selected

13 results

0 selected